{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:40:40Z","timestamp":1762875640608},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.endonu.2014.06.004","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T20:18:47Z","timestamp":1411589927000},"page":"541-547","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Par\u00e1metros de control gluc\u00e9mico en pacientes con diabetes tipo 2 no insulinizados derivados a consulta de Endocrinolog\u00eda, y grado de implementaci\u00f3n del consenso nacional sobre el tratamiento de la hiperglucemia"],"prefix":"10.1016","volume":"61","author":[{"given":"Sharona","family":"Azriel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentino","family":"Casal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bel\u00e9n","family":"Dalama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Varillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1frica","family":"Villarroel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Barber\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2014.06.004_bib0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMcp1103643","article-title":"Diagnosis of diabetes","volume":"367","author":"Inzucchi","year":"2012","journal-title":"N Eng J Med"},{"key":"10.1016\/j.endonu.2014.06.004_bib0010","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.medcli.2012.03.015","article-title":"Prevenci\u00f3n de la diabetes mellitus tipo 2","volume":"139","author":"Soriguer","year":"2012","journal-title":"Med Clin"},{"key":"10.1016\/j.endonu.2014.06.004_bib0015","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/diacare.27.11.2616","article-title":"Direct healthcare costs of diabetic patients in Spain","volume":"27","author":"Oliva","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endonu.2014.06.004_bib0020","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.endonu.2014.06.004_bib0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2014.06.004_bib0030","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/0003-4819-151-6-200909150-00137","article-title":"Glucose control and cardiovascular disease in type-2 diabetes","volume":"151","author":"Kelly","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.endonu.2014.06.004_bib0035","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2014.06.004_bib0040","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.endonu.2014.06.004_bib0045","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2014.06.004_bib0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1134-3230(10)65006-5","article-title":"Recomendaciones para el tratamiento farmacol\u00f3gico de la hiperglucemia en la diabetes tipo 2","volume":"26","author":"Men\u00e9ndez Torre","year":"2010","journal-title":"Avances en Diabetolog\u00eda"},{"key":"10.1016\/j.endonu.2014.06.004_bib0055","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endonu.2014.06.004_bib0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.endonu.2014.06.004_bib0065","first-page":"S1","article-title":"Clinical Practice Guidelines for the prevention and management of diabetes in Canada","volume":"32","year":"2008","journal-title":"Can J Diabetes"},{"issue":"Suppl 1","key":"10.1016\/j.endonu.2014.06.004_bib0165","first-page":"S1","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endonu.2014.06.004_bib0075","first-page":"143","article-title":"Diabetes mellitus y riesgo cardiovascular Recomendaciones del Grupo de Trabajo Diabetes Mellitus y Enfermedad Cardiovascular de la Sociedad Espa\u00f1ola de Diabetes 2006. Documento de Consenso","volume":"22","author":"Ascaso","year":"2006","journal-title":"Av Diabetol"},{"key":"10.1016\/j.endonu.2014.06.004_bib0170","first-page":"782","article-title":"Consenso espa\u00f1ol 1995 para la evaluaci\u00f3n de la obesidad y para la realizaci\u00f3n de estudios epidemiol\u00f3gicos","volume":"107","year":"1996","journal-title":"Med Clin"},{"key":"10.1016\/j.endonu.2014.06.004_bib0085","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP)-Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.endonu.2014.06.004_bib0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.avdiab.2013.07.002","article-title":"Estudio observacional de eficacia y seguridad del cambio deinsulina NPH a glargina en atenci\u00f3n primaria. Estudio LAURA","volume":"29","author":"Mata-Cases","year":"2013","journal-title":"Av Diabetol"},{"issue":"Suppl 1","key":"10.1016\/j.endonu.2014.06.004_bib0095","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1007\/s00592-009-0158-8","article-title":"Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain","volume":"47","author":"Costi","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.endonu.2014.06.004_bib0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.medcli.2011.06.026","article-title":"Relaci\u00f3n del grado de control gluc\u00e9mico con las caracter\u00edsticas de la diabetes y el tratamiento de la hiperglucemia en la diabetes tipo 2. Estudio DIABES","volume":"138","author":"P\u00e9rez","year":"2012","journal-title":"Med Clin."},{"key":"10.1016\/j.endonu.2014.06.004_bib0105","first-page":"87","article-title":"Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain","volume":"2","author":"Rae","year":"2008","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.endonu.2014.06.004_bib0110","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2014.06.004_bib0115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1463-1326.2008.00980.x","article-title":"Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7-8% A1c levels The TULIP study","volume":"11","author":"Blickl\u00e9","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.endonu.2014.06.004_bib0120","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1134-3230(10)64016-1","article-title":"Diabetolog\u00eda. Tema de actualidad. Triple terapia en diabetes tipo 2: revisi\u00f3n sistem\u00e1tica de la evidencia disponible","volume":"26","author":"Ortega Mill\u00e1n","year":"2010","journal-title":"Av Diabetol"},{"key":"10.1016\/j.endonu.2014.06.004_bib0125","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.2337\/diacare.26.8.2238","article-title":"Insulin 70\/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis","volume":"26","author":"Schwartz","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endonu.2014.06.004_bib0130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1742-1241.2010.02544.x","article-title":"Patient adherence to medication requirements for therapy of type 2 diabetes","volume":"65","author":"Bailey","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.endonu.2014.06.004_bib0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.avdiab.2012.07.001","article-title":"El nuevo \u00abPosition statement of the ADA\/EASD on the management of hyperglycemia in type 2 diabetes\u00bb. Perspectiva desde el Grupo de Trabajo de Consensos y Gu\u00edas Cl\u00ednicas de la Sociedad Espa\u00f1ola de Diabetes","volume":"28","author":"Men\u00e9ndenz Torre","year":"2012","journal-title":"Av Diabetol"},{"key":"10.1016\/j.endonu.2014.06.004_bib0140","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00125-002-0822-9","article-title":"Hypoglycaemia:The limiting factor in the glycae-mic management of type I and type II diabetes","volume":"45","author":"Cryer","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.endonu.2014.06.004_bib0145","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.2337\/diacare.28.10.2543","article-title":"Psychological insulin resistance in patients with type 2 diabetes","volume":"28","author":"Polonsky","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.endonu.2014.06.004_bib0150","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1210\/jc.2007-2871","article-title":"Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes","volume":"93","author":"Linn","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2014.06.004_bib0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1742-1241.2011.02880.x","article-title":"Outcomes withinsulin glargine in patients with type 2 diabetes previously on NPH insulin: Evidence from clinical practice in Spain","volume":"66","author":"Delgado","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.endonu.2014.06.004_bib0160","doi-asserted-by":"crossref","first-page":"9559","DOI":"10.1111\/j.1742-1241.2012.03000.x","article-title":"Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: An observational study","volume":"66","author":"G\u00f3mez-Peralta","year":"2012","journal-title":"Int J Clin Pract."}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092214001739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092214001739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T10:40:57Z","timestamp":1565865657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092214001739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1575092214001739"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2014.06.004","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Par\u00e1metros de control gluc\u00e9mico en pacientes con diabetes tipo 2 no insulinizados derivados a consulta de Endocrinolog\u00eda, y grado de implementaci\u00f3n del consenso nacional sobre el tratamiento de la hiperglucemia","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endonu.2014.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 SEEN. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}